Nuclear Medicine News and Research

RSS

Nuclear medicine is a branch or specialty of medicine and medical imaging that uses radioactive isotopes (radionuclides) and relies on the process of radioactive decay in the diagnosis and treatment of disease. In nuclear medicine procedures, radionuclides are combined with other chemical compounds or pharmaceuticals to form radiopharmaceuticals.

FDA approves ultrasmall silica inorganic nanoparticle INDA for targeted molecular imaging of cancer

Researchers at Memorial Sloan-Kettering Cancer Center's Nanotechnology Center, along with collaborators at Cornell University and Hybrid Silica Technologies, have received approval for their first Investigational New Drug Application from the US Food and Drug Administration for an ultrasmall silica inorganic nanoparticle platform for targeted molecular imaging of cancer, which may be useful for cancer treatment in the future.

31 Jan 2011

Radia announces diagnostic imaging services partnership with Jefferson Healthcare

Radia, is proud to announce a diagnostic imaging services partnership with Jefferson Healthcare commencing on January 1, 2011. Jefferson Healthcare, located in Port Townsend, WA, is a comprehensive healthcare center providing services for the more than 29,500 residents of Jefferson County.

31 Jan 2011

Despite reimbursement cuts the diagnostic imaging market to grow at 5% over next five years: MRG

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, although the overall diagnostic imaging market has been limited by reimbursement cuts and poor economic conditions, the next five years will see unit growth of approximately 5%.

27 Jan 2011

SNM commends FDA Advisory Committee recommendation for florbetapir approval

The Society of Nuclear Medicine (SNM) commends the U.S. Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee on its recent recommendation for conditional approval of a new imaging agent, florbetapir.

25 Jan 2011

Spectrum submits Post Approval Supplement for removal of bioscan requirement for Indium-111 ZEVALIN

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that on Thursday, January 20, 2011, it submitted a Post Approval Supplement containing data supporting the removal of the Indium-111 ZEVALIN® pre-treatment imaging evaluation, more commonly referred to as the "bioscan" requirement.

24 Jan 2011

Eckert & Ziegler receives European Commission's indefinite approval for YTTRIGA

Eckert & Ziegler Strahlen- und Medizintechnik AG, a firm specializing in radioactive compounds for the treatment of cancer, has renewed the approval of its drug YTTRIGA (Yttrium-90 chloride) by the European Commission. Five years ago the European Medicines Agency EMA approved this drug for the first time and as a result of the current renewal process the drug has now been granted an indefinite approval.

24 Jan 2011

RAS includes Merge iConnect solution

Merge Healthcare, a leading health IT solutions provider, today announced that Radiology Associates of Sacramento (RAS), the largest private radiology practice in Northern California, has expanded their Merge solution suite to include Merge iConnect.

12 Jan 2011

Researchers design new electronic technology equipment for detecting live cellular processes

The electronic technology equipment designed by the researchers- which is in patent process-is based on molecular imaging, a type of biomedical imaging capable of detecting live cellular processes. "These techniques differ from conventional medical imaging in that the information they show is function not form, which means that they are capable of showing the malfunctioning of an organ before the malfunction turns into an anatomical change", Juan Jos- Vaquero explained.

12 Jan 2011

Enlight Biosciences forms new oral drug delivery technology company

Entrega, Inc., a new company developing oral drug delivery technologies, today announced its formation by Enlight Biosciences, a Boston-based company established in partnership with a group of leading global pharmaceutical companies.

10 Jan 2011

CoreLab Partners releases ImagEngine imaging sciences application

CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm, Inc and Medifacts International, has launched a new advanced imaging application named ImagEngine®.

10 Jan 2011

RadNet completes acquisition of Imaging On Call

4 Jan 2011

Clinical Decision Support Systems help reduce unnecessary CT and MRI scans

Researchers from Virginia Mason Medical Center in Seattle, WA, have found that clinical decision support systems can help reduce inappropriate medical imaging, including unnecessary computed tomography (CT) and magnetic resonance imaging (MRI) scans, according to a study in the January issue of the Journal of the American College of Radiology (www.jacr.org).

4 Jan 2011

Non-radiologist physicians are paid more for NDI by Medicare than radiologists

Researchers have found that Medicare payments for non-invasive medical imaging, including magnetic resonance imaging and computed tomography scans, are now higher to non-radiologists than to radiologists, according to a study in the January issue of the Journal of the American College of Radiology.

4 Jan 2011

Reviewing medical imaging on portable media presents a problematic venture

Radiologists and referring clinicians frequently use portable media to review patient medical images acquired at outside imaging centers, including magnetic resonance imaging and computed tomography scans, but issues regarding access, importability, and viewing of these portable media exist, according to a study in the January issue of the Journal of the American College of Radiology.

4 Jan 2011

18F-FDG PET scans help evaluate cognitive dysfunction of pediatric fever-induced epilepsy

Sudden, catastrophic childhood epilepsy is a parent's worst nightmare, especially in the case of fever-induced refractory epileptic encephalopathy in school-age children (FIRES). While not much is known about the condition, new research published in the January issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) scans can offer an evaluation of cognitive dysfunction of FIRES, its evolution and further prognosis.

4 Jan 2011

Positron granted U.S. patents for quantum photodetectors

Positron Corporation, a leading molecular imaging company specializing in the field of nuclear cardiology, today announced it has received two U.S. patents for its proprietary quantum photodetectors.

24 Dec 2010

RadNet to acquire Imaging On Call

RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 198 fully-owned and operated outpatient imaging centers, today reported it has executed a definitive agreement to acquire Imaging On Call, LLC for $5.5 million plus contingent compensation of up to an additional $2.5 million if Imaging On Call achieves certain 2011 performance milestones.

22 Dec 2010

PEG-Prom encased nanoparticle aids in cancer detection and treatment

In a proof of principal study in mice, scientists at Johns Hopkins and the Virginia Commonwealth University have shown that a set of genetic instructions encased in a nanoparticle can be used as an "ignition switch" to rev up gene activity that aids cancer detection and treatment.

16 Dec 2010

Mayo clinic creates new computerized radiation tracking system

Mayo Clinic is initiating a new imaging exam tracking system that, among other things, enables a comprehensive view of a patient's radiation exposures over time.

13 Dec 2010

Toshiba to market Elekta's products and clinical solutions in Japanese radiotherapy market

Elekta K.K., a wholly owned subsidiary of Elekta AB, has entered into a sales and marketing agreement with Toshiba Medical Systems Corporation in Japan.

From Elekta 10 Dec 2010